Director Dealing

January 08, 2016

The Company has received notification from Vulpes Life Sciences Fund (“Vulpes”) that it has a total direct and indirect interest in 36,573,125 ordinary shares of 1p each in the capital of the Company (“Ordinary Shares”) equivalent to 16.04% of Proteome Sciences’ total issued share capital. The Company would also like to announce that by virtue of Martin Diggle being a Director of both Vulpes and the Company, he now has an interest in 36,573,125 Ordinary Shares of the Company representing 16.04% of the issued share capital of the Company.

Back to News